Business

CCI approves acquisition of Micro Life Sciences Private Limited by South Elm Investments B.V.

Published

on

The Competition Commission of India (CCI) approves acquisition of Micro Life Sciences Private Limited by South Elm Investments B.V. The shareholders of SEI are certain private equity funds managed by Warburg Pincus LLC, whereas, SEI is an investment holding company incorporated under the laws of Netherlands.

Target is a company incorporated in India, which is primarily engaged in the following business activities in India along with subsidiaries. It manufactures and sells medical devices in various categories such as stents, heart valves, orthopedic implants, and endo-surgery products (such as sutures, staplers, meshes and intrauterine devices) and over the counter (OTC) products like COVID self-test kits and pregnancy test kits, in India. The Target (through its subsidiaries) is engaged in B2C sale of certain specialized medical devices to hospitals and has research and development (R&D) facilities for in-vitro diagnostics analyzers and reagents.

Complete News: PIB

Advertisement

Trending

Exit mobile version